News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

ImmunoGen, Inc. (IMGN) Announces Webcast of Presentation at the 31st Annual J.P. Morgan Healthcare Conference


1/2/2013 6:19:16 AM

ImmunoGen, Inc. (Nasdaq: IMGN), a biotechnology company that develops anticancer therapeutics using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced that Daniel Junius, President and CEO, will present at the upcoming 31st Annual J.P. Morgan Healthcare Conference in San Francisco. The presentation is scheduled for 8:00 am PT on January 7, 2013 and will include information about IMGN289, which is on track to become the fourth wholly owned ImmunoGen compound to advance into clinical testing.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES